Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Tumori|March 17, 2016
Safety of combination treatment with imatinib mesylate, carboplatin, and cetuximab in a patient with multiple cancers: a case reportLaura Pala, Cristiana Bergamini, Martina Imbimbo, et al.
The Cochrane Database of Systematic Reviews|May 27, 2025
Adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) for the treatment of people with resected stage I to III non-small-cell lung cancer and EGFR mutationMario Occhipinti, Martina Imbimbo, Roberto Ferrara, et al.
Oral Oncology|July 9, 2014
Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancerPaolo Bossi, Laura Locati, Cristiana Bergamini, et al.
Tumori|August 29, 2019
Unusual skin toxicity associated with sustained disease response induced by nivolumab in a patient with non-small cell lung cancerGiulia Galli, Claudia Proto, Mara Cossa, et al.
Critical Reviews in Oncology/Hematology|October 5, 2010
A comprehensive outlook on intracerebral therapy of malignant gliomasCarlo Buonerba, Giuseppe Di Lorenzo, Alfredo Marinelli, et al.
Plos One|July 13, 2016
What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research ActivitiesAnna Moretti, Michele Ghidini, Carmine De Angelis, et al.
Cancer Biology & Therapy|March 13, 2014
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapyLaura D Locati, Federica Perrone, Barbara Cortelazzi, et al.
Oncotarget|September 24, 2017
Concomitant EML4-ALK rearrangement and EGFR mutation in non-small cell lung cancer patients: a literature review of 100 casesGiuseppe Lo Russo, Martina Imbimbo, Giulia Corrao, et al.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2018
Uncommon mutations in epidermal growth factor receptor and response to first and second generation tyrosine kinase inhibitors: A case series and literature reviewGiulia Galli, Giulia Corrao, Martina Imbimbo, et al.
Journal of Clinical Medicine|January 10, 2026
ChronoimmunoTOX: A Single-Institution Retrospective Study on How the Time of Administration Impacts Immune Checkpoint Inhibitor Efficacy and Toxicity in MelanomaAlessandro Nepote, Gilles Burghgraeve, Martino Pedrani, et al.
Pageof 6